» Articles » PMID: 33775162

Association of Dyslipidaemia with Osteoporosis in Postmenopausal Women

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2021 Mar 29
PMID 33775162
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the association of dyslipidaemia with osteoporosis in postmenopausal women.

Methods: Data from 160 postmenopausal women with newly diagnosed osteoporosis (osteoporosis group) and 156 healthy controls (control group) were retrospectively reviewed from 2016 to 2020. The primary outcomes were laboratory values assessed by a multivariate binary logistic regression model.

Results: Factors that greatly increased the risk of being in the osteoporosis group included high low-density lipoprotein (LDL) and low high-density lipoprotein (HDL) levels. The osteoporosis group had lower HDL and higher LDL levels than the control group. A multivariate binary logistic regression model showed that lower HDL and higher LDL levels were the only variables that were significantly associated with osteoporosis (odds ratio 1.86, 95% confidence interval: 3.66-4.25 and odds ratio 1.47, 95% confidence interval: 1.25-2.74, respectively).

Conclusion: Low HDL and high LDL levels may be associated with the occurrence of osteoporosis in postmenopausal women.

Citing Articles

Correlation between serum high-density lipoprotein cholesterol and bone mineral density in vitamin D-deficient populations.

An M, Wu C, Feng S, Zhu L, Yang W, Ran L J Bone Miner Metab. 2025; .

PMID: 39814987 DOI: 10.1007/s00774-024-01572-w.


Acute hyperlipidemia has transient effects on large-scale bone regeneration in male mice.

Yamamoto de Almeida L, Dietrich C, Duverger O, Lee J Sci Rep. 2024; 14(1):25610.

PMID: 39463386 PMC: 11514207. DOI: 10.1038/s41598-024-76992-9.


Assessment of bone tissue cytoarchitectonics by 2D H NMR relaxometry maps.

Orban E, Pap Z, Sipos R, Fechete R J Biol Phys. 2024; 50(3-4):255-269.

PMID: 38935192 PMC: 11492200. DOI: 10.1007/s10867-024-09658-2.


MEDAG expression in vitro and paeoniflorin alleviates bone loss by regulating the MEDAG/AMPK/PPARγ signaling pathway .

Liu H, Chang Z, Liu S, Zhu R, Ma J, Lu X Heliyon. 2024; 10(1):e24241.

PMID: 38226230 PMC: 10788805. DOI: 10.1016/j.heliyon.2024.e24241.


Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study.

Ceolin C, Scala A, DallAgnol M, Ziliotto C, Delbarba A, Facondo P J Endocrinol Invest. 2023; 47(2):401-410.

PMID: 37450195 PMC: 10859333. DOI: 10.1007/s40618-023-02156-7.


References
1.
Lee K, Lee G, Yang J, Moon M . Perturbations of Lipids and Oxidized Phospholipids in Lipoproteins of Patients with Postmenopausal Osteoporosis Evaluated by Asymmetrical Flow Field-Flow Fractionation and Nanoflow UHPLC-ESI-MS/MS. Antioxidants (Basel). 2020; 9(1). PMC: 7022717. DOI: 10.3390/antiox9010046. View

2.
Papandreou P, Agakidis C, Scouroliakou M, Karagiozoglou-Lampoudi T, Kaliora A, Kalogeropoulos N . Early Postnatal Changes of Bone Turnover Biomarkers in Very Low-Birth-Weight Neonates-The Effect of Two Parenteral Lipid Emulsions with Different Polyunsaturated Fatty Acid Content: A Randomized Double-Blind Study. JPEN J Parenter Enteral Nutr. 2019; 44(2):361-369. DOI: 10.1002/jpen.1533. View

3.
Grundy S, Cleeman J, Merz C, Brewer Jr H, Clark L, Hunninghake D . Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110(2):227-39. DOI: 10.1161/01.CIR.0000133317.49796.0E. View

4.
Inzerillo A, Epstein S . Osteoporosis and diabetes mellitus. Rev Endocr Metab Disord. 2004; 5(3):261-8. DOI: 10.1023/B:REMD.0000032415.83124.20. View

5.
Cui R, Zhou L, Li Z, Li Q, Qi Z, Zhang J . Assessment risk of osteoporosis in Chinese people: relationship among body mass index, serum lipid profiles, blood glucose, and bone mineral density. Clin Interv Aging. 2016; 11:887-95. PMC: 4938238. DOI: 10.2147/CIA.S103845. View